1.
Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology. Swiss Med Wkly [Internet]. 2023 Jul. 26 [cited 2025 Oct. 13];153(7):40113. Available from: https://www.smw.ch/index.php/smw/article/view/3383